151 related articles for article (PubMed ID: 3884737)
21. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
22. Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan.
Chung DC; Ko YC; Chen CJ; Wu CC; Chen ER; Liaw YF; Hwang SJ
J Med Virol; 1988 Dec; 26(4):411-8. PubMed ID: 3209993
[TBL] [Abstract][Full Text] [Related]
23. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver.
Ryley NG; Heryet AR; Goldin R; Monjardino J; Saldanha J; Fleming KA
Histopathology; 1992 Apr; 20(4):331-7. PubMed ID: 1577410
[TBL] [Abstract][Full Text] [Related]
24. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
25. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland.
Laskus T; Radkowski M; Lupa E; Slusarczyk J; Cianciara J; Halama G; Nowicka R
J Hepatol; 1992 May; 15(1-2):114-7. PubMed ID: 1324268
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective (1970-1984) serological study of delta antigen and antibody. Observations on seroconversion and absence of delta in non-A, non-B hepatitis].
Stroun J; Peitrequin R; Frei PC
Schweiz Med Wochenschr; 1987 Feb; 117(9):307-14. PubMed ID: 3105053
[TBL] [Abstract][Full Text] [Related]
29. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC
Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
32. Clinical and serological outcome of acute delta infection.
Buti M; Estebán R; Jardi R; Allende H; Estebán JI; Genesca J; Guardia J
J Hepatol; 1987 Aug; 5(1):59-64. PubMed ID: 3655311
[TBL] [Abstract][Full Text] [Related]
33. Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis.
Wagner N; Rotthauwe HW; Becker M; Dienes HP; Mertens T; Födisch HJ; Brackmann HH
Eur J Pediatr; 1992 Feb; 151(2):90-4. PubMed ID: 1537369
[TBL] [Abstract][Full Text] [Related]
34. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.
Raimondo G; Smedile A; Gallo L; Balbo A; Ponzetto A; Rizzetto M
Lancet; 1982 Jan; 1(8266):249-51. PubMed ID: 6120275
[TBL] [Abstract][Full Text] [Related]
35. Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.
Shattock AG; Irwin FM; Morgan BM; Hillary IB; Kelly MG; Fielding JF; Kelly DA; Weir DG
Br Med J (Clin Res Ed); 1985 May; 290(6479):1377-80. PubMed ID: 3922501
[TBL] [Abstract][Full Text] [Related]
36. A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazonas State, Venezuela.
Duarte MC; Cardona N; Poblete F; González K; García M; Pacheco M; Botto C; Pujol FH; Williams JR
Trop Med Int Health; 2010 Aug; 15(8):924-33. PubMed ID: 20561309
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
[TBL] [Abstract][Full Text] [Related]
38. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
[TBL] [Abstract][Full Text] [Related]
39. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation.
Borghesio E; Rosina F; Smedile A; Lagget M; Niro MG; Marinucci G; Rizzetto M
Hepatology; 1998 Mar; 27(3):873-6. PubMed ID: 9500721
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
